Mia M Gaudet1, Brian D Carter1, Louise A Brinton2, Roni T Falk2, Inger T Gram3, Juhua Luo4, Roger L Milne5, Sarah J Nyante2,6, Elisabete Weiderpass3,7,8,9, Laura E Beane Freeman2, Dale P Sandler10, Kim Robien11, Kristin E Anderson12, Graham G Giles5, Wendy Y Chen13,14, Diane Feskanich13, Tonje Braaten3, Claudine Isaacs15,16, Lesley M Butler17, Woon-Puay Koh18, Alicja Wolk19, Hans-Olov Adami7,20, Emily White21,22, Karen L Margolis23, Michael J Thun1, Susan M Gapstur1. 1. Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA. 3. Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway. 4. Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, IN, USA. 5. Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, VIC, Australia and Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia. 6. Department of Radiology, University of North Carolina, Chapel Hill, NC, USA. 7. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 8. Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway. 9. Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland. 10. Epidemiology Branch, National Institute of Environmental Health Sciences, NIH/DHHS, Research Triangle Park, NC, USA. 11. Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC, USA. 12. School of Public Health, University of Minnesota, Minneapolis, MN, USA. 13. Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 14. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. 15. Department of Oncology, School of Medicine, Georgetown University, Washington, DC, USA. 16. Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC, USA. 17. University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. 18. Duke-NUS Graduate Medical School Singapore, Singapore, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore. 19. Department of Environmental Medicine, Karolinska Institute, Stockholm, Sweden. 20. Department of Epidemiology, Harvard T.H. Chan School of Public Health Community, Boston, MA, USA. 21. Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 22. Department of Epidemiology, University of Washington, Seattle, Washington, USA. 23. HealthPartners Institute for Education and Research, Minneapolis, MN, USA.
Abstract
Background: The 2014 US Surgeon General's report noted research gaps necessary to determine a causal relationship between active cigarette smoking and invasive breast cancer risk, including the role of alcohol consumption, timing of exposure, modification by menopausal status and heterogeneity by oestrogen receptor (ER) status. Methods: To address these issues, we pooled data from 14 cohort studies contributing 934 681 participants (36 060 invasive breast cancer cases). Cox proportional hazard regression models were used to calculate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). Results: Smoking duration before first birth was positively associated with risk ( P -value for trend = 2 × 10 -7 ) with the highest HR for initiation >10 years before first birth (HR = 1.18, CI 1.12-1.24). Effect modification by current alcohol consumption was evident for the association with smoking duration before first birth ( P -value=2×10 -4 ); compared with never-smoking non-drinkers, initiation >10 years before first birth was associated with risk in every category of alcohol intake, including non-drinkers (HR = 1.15, CI 1.04-1.28) and those who consumed at least three drinks per day (1.85, 1.55-2.21). Associations with smoking before first birth were limited to risk of ER+ breast cancer ( P -value for homogeneity=3×10 -3 ). Other smoking timing and duration characteristics were associated with risk even after controlling for alcohol, but were not associated with risk in non-drinkers. Effect modification by menopause was not evident. Conclusions: Smoking, particularly if initiated before first birth, was modestly associated with ER+ breast cancer risk that was not confounded by amount of adult alcohol intake. Possible links with breast cancer provide additional motivation for young women to not initiate smoking.
Background: The 2014 US Surgeon General's report noted research gaps necessary to determine a causal relationship between active cigarette smoking and invasive breast cancer risk, including the role of alcohol consumption, timing of exposure, modification by menopausal status and heterogeneity by oestrogen receptor (ER) status. Methods: To address these issues, we pooled data from 14 cohort studies contributing 934 681 participants (36 060 invasive breast cancer cases). Cox proportional hazard regression models were used to calculate multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs). Results: Smoking duration before first birth was positively associated with risk ( P -value for trend = 2 × 10 -7 ) with the highest HR for initiation >10 years before first birth (HR = 1.18, CI 1.12-1.24). Effect modification by current alcohol consumption was evident for the association with smoking duration before first birth ( P -value=2×10 -4 ); compared with never-smoking non-drinkers, initiation >10 years before first birth was associated with risk in every category of alcohol intake, including non-drinkers (HR = 1.15, CI 1.04-1.28) and those who consumed at least three drinks per day (1.85, 1.55-2.21). Associations with smoking before first birth were limited to risk of ER+ breast cancer ( P -value for homogeneity=3×10 -3 ). Other smoking timing and duration characteristics were associated with risk even after controlling for alcohol, but were not associated with risk in non-drinkers. Effect modification by menopause was not evident. Conclusions: Smoking, particularly if initiated before first birth, was modestly associated with ER+ breast cancer risk that was not confounded by amount of adult alcohol intake. Possible links with breast cancer provide additional motivation for young women to not initiate smoking.
Authors: Xiaonan Xue; Mimi Y Kim; Mia M Gaudet; Yikyung Park; Moonseong Heo; Albert R Hollenbeck; Howard D Strickler; Marc J Gunter Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-01-04 Impact factor: 4.254
Authors: Kathleen Conway; Sharon N Edmiston; Lisa Cui; S Scott Drouin; Jingzhong Pang; Mei He; Chiu-Kit Tse; Joseph Geradts; Lynn Dressler; Edison T Liu; Robert Millikan; Beth Newman Journal: Cancer Res Date: 2002-04-01 Impact factor: 12.701
Authors: Mia M Gaudet; Susan M Gapstur; Juzhong Sun; W Ryan Diver; Lindsay M Hannan; Michael J Thun Journal: J Natl Cancer Inst Date: 2013-02-28 Impact factor: 13.506
Authors: Amy Trentham-Dietz; Hazel B Nichols; Kathleen M Egan; Linda Titus-Ernstoff; John M Hampton; Polly A Newcomb Journal: Epidemiology Date: 2007-09 Impact factor: 4.822
Authors: Yujing J Heng; Susan E Hankinson; Jun Wang; Ludmil B Alexandrov; Christine B Ambrosone; Victor P de Andrade; Adam M Brufsky; Fergus J Couch; Tari A King; Francesmary Modugno; Celine M Vachon; A Heather Eliassen; Rulla M Tamimi; Peter Kraft Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-01-13 Impact factor: 4.254
Authors: Kristina M Jordahl; Kathleen E Malone; Michelle L Baglia; Meghan R Flanagan; Mei-Tzu C Tang; Peggy L Porter; Christopher I Li Journal: Breast Cancer Res Treat Date: 2022-03-27 Impact factor: 4.872
Authors: Laurel A Habel; Weiva Sieh; Russell B McBride; Kezhen Fei; Joseph H Rothstein; Stacey E Alexeeff; Xiaoyu Song; Lori C Sakoda; Valerie McGuire; Ninah Achacoso; Luana Acton; Rhea Y Liang; Jafi A Lipson; Martin J Yaffe; Daniel L Rubin; Alice S Whittemore Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-17 Impact factor: 4.254
Authors: Enda M Byrne; Manuel A R Ferreira; Angli Xue; Sara Lindström; Xia Jiang; Jian Yang; Douglas F Easton; Naomi R Wray; Georgia Chenevix-Trench Journal: Schizophr Bull Date: 2019-10-24 Impact factor: 9.306
Authors: Kwang-Pil Ko; Shana J Kim; Tomasz Huzarski; Jacek Gronwald; Jan Lubinski; Henry T Lynch; Susan Armel; Sue K Park; Beth Karlan; Christian F Singer; Susan L Neuhausen; Steven A Narod; Joanne Kotsopoulos Journal: Int J Cancer Date: 2018-01-25 Impact factor: 7.396
Authors: Nadine Andrieu; David E Goldgar; Hongyan Li; Mary Beth Terry; Antonis C Antoniou; Kelly-Anne Phillips; Karin Kast; Thea M Mooij; Christoph Engel; Catherine Noguès; Dominique Stoppa-Lyonnet; Christine Lasset; Pascaline Berthet; Veronique Mari; Olivier Caron; Daniel Barrowdale; Debra Frost; Carole Brewer; D Gareth Evans; Louise Izatt; Lucy Side; Lisa Walker; Marc Tischkowitz; Mark T Rogers; Mary E Porteous; Katie Snape; Hanne E J Meijers-Heijboer; Johan J P Gille; Marinus J Blok; Nicoline Hoogerbrugge; Mary B Daly; Irene L Andrulis; Saundra S Buys; Esther M John; Sue-Anne McLachlan; Michael Friedlander; Yen Y Tan; Ana Osorio; Trinidad Caldes; Anna Jakubowska; Jacques Simard; Christian F Singer; Edith Olah; Marie Navratilova; Lenka Foretova; Anne-Marie Gerdes; Marie-José Roos-Blom; Brita Arver; Håkan Olsson; Rita K Schmutzler; John L Hopper; Roger L Milne; Douglas F Easton; Flora E Van Leeuwen; Matti A Rookus Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-12-02 Impact factor: 4.254
Authors: Inger T Gram; Song-Yi Park; Gertraud Maskarinec; Lynne R Wilkens; Christopher A Haiman; Loïc Le Marchand Journal: Int J Epidemiol Date: 2019-04-01 Impact factor: 7.196
Authors: Niki Dimou; James Yarmolinsky; Emmanouil Bouras; Konstantinos K Tsilidis; Richard M Martin; Sarah J Lewis; Inger T Gram; Marije F Bakker; Hermann Brenner; Jane C Figueiredo; Renée T Fortner; Stephen B Gruber; Bethany van Guelpen; Li Hsu; Rudolf Kaaks; Sun-Seog Kweon; Yi Lin; Noralane M Lindor; Polly A Newcomb; Maria-Jose Sánchez; Gianluca Severi; Hilary A Tindle; Rosario Tumino; Elisabete Weiderpass; Marc J Gunter; Neil Murphy Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-03-02 Impact factor: 4.254